FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to a pharmaceutical composition of such an active agent, as sucralfate for treating disorders, e.g. gastric ulcers, duodenal ulcers, acute gastritis, symptomatic chronic gastritis, gastropathy caused by the intake of anti-inflammatory agents, gastroesophageal reflux disease characterised by the fact that is contains one or more phospholipids.
EFFECT: invention refers to using phospholipids in a combination with the above active agents when administered orally for the purpose of improving the taste of the preparation, and to using phospholipids in a combination with the above active agents when administered orally for the purpose of treating disorders, including gastrointestinal irritation, for the synergetic enhancement of the anti-ulcer effect.
19 cl, 15 ex
